Table 5.
Differentially abundant osteoclast proteins identified using Cten.
| Symbol | Name | Female DKO | Male DKO |
|---|---|---|---|
| s100a8* | Protein S100-A8 | 0.13 | 0.18 |
| S100a9$ | Protein S100-A9 | 0.17 | 0.17 |
| CAMP | Cathelicidin antimicrobial peptide | 0.21 | 0.42 |
| Ltf | Lactotransferrin | 0.22 | 0.21 |
| Ctsk* | Cathepsin K | 0.24 | 0.39 |
| Ppbp# | Chemokine (C-X-C motif) ligand 7, isoform CRA_b | 0.24 | 0.52 |
| Itgam | Integrin αM | 0.26 | 0.39 |
| Ngp | Neutrophilic granule protein | 0.28 | 0.30 |
| Itgb2* | Integrin beta-2 | 0.28 | 0.39 |
| Rac2 | Ras-related C3 botulinum toxin substrate 2 | 0.28 | 0.38 |
| Acp5# | Tartrate-resistant acid phosphatase type 5 | 0.29 | 0.33 |
| Icn2 | Neutrophil gelatinase-associated lipocalin | 0.29 | 0.31 |
| msn | moesin | 0.29 | 0.53 |
| Sash3* | SAM and SH3 domain-containing protein 3 | 0.30 | 0.41 |
| Cybb | Cytochrome B 245-β-chain | 0.30 | 0.42 |
| Lyz2* | Lysozyme C-2 | 0.31 | 0.31 |
| Mmp8 | Neutrophil collagenase | 0.34 | 0.38 |
| Aldh3b1 | Aldehyde dehydrogenase family 3 member B1 | 0.34 | 0.51 |
| FCGR2B | Fc fragment of IgG receptor IIb | 0.34 | 0.45 |
| Ncf2* | Neutrophil cytosol factor 2 | 0.34 | 0.36 |
| MMP9 | Matrix Metalloproteinase 9 | 0.35 | 0.33 |
| Ncf1 | Neutrophil cytosol factor 1 | 0.35 | 0.38 |
| Emb | Embigen | 0.36 | 0.53 |
| Hk3 | Hexokinase-3 | 0.37 | 0.37 |
| Ptpn6# | Isoform 2 of Tyrosine-protein phosphatase non-receptor type 6 | 0.37 | 0.40 |
| lcp1# | Plastin-2 | 0.38 | 0.40 |
| Grn | Granulins | 0.39 | 0.50 |
| Fermt3 | Fermitin family homolog 3 | 0.41 | 0.53 |
| Fgr | Tyrosine-protein kinase Fgr | 0.42 | 0.40 |
| Cfp# | Properdin | 0.44 | 0.47 |
| Prtn3* | Myeloblastin | 0.46 | 0.50 |
| Lgals3* | Galectin-3-binding protein | 0.48 | 0.50 |
| Spn | Leukosialin | 0.50 | 0.42 |
| Tcirg1# | V-type proton ATPase subunit a | 0.51 | 0.49 |
| Tpd52* | Tumor protein D52 | 0.51 | 0.42 |
| Hcls1 | Hematopoietic lineage cell-specific protein | 0.54 | 0.44 |
All proteins in Table 5 are highly expressed cell specific (HECS) osteoclast genes in CTen and all except S100A9 ($) are also listed in a published RNAseq data set obtained from osteocytes undergoing in vitro maturation.
Denotes gene that increases during in vitro osteocyte maturation and is also listed in table Table S2.
Denotes gene that decreases during in vitro osteocyte maturation and is also listed in table S3.